Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches.

Mater Today Bio · 2022 · PMC8858997 · PMID 35243292

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The administration of MAPs led to pharmacokinetic profiles that started with a decreasing trend in TFV concentrations followed by significantly different plasmatic peaks (T max ) at 0.09 ± 0.07 and 0.82 ± 0.41 days for dissolving and implantable MAPs, respectively.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.